Monsanto To Back A Federal Marijuana Decriminalization Bill - Just In Time To Introduce Its New Super-Hybridized Pot Seeds

 
      

Monsanto To Back A Federal Marijuana Decriminalization Bill – Just In Time To Introduce Its New Super-Hybridized Pot Seeds

Marijuana legalization advocates can count on the support of perhaps their strangest bedfellow to date: The International seed and herbicide manufacturing giant, Monsanto.  According to a Monsanto spokesman, Monsanto has pledged to put money and political muscle behind the popular issue.

Cited as “major contributing factors” behind the corporation’s unprecedented decision are the recent legalization of recreational marijuana in the states of Washington and Colorado, and the legalization of medical marijuana in 17 other states plus the District of Columbia. 

“With the rapidly-increasing state recognition of the medicinal virtues of marijuana and cannabinoids, its reclassification and/or removal from the Federal list of banned substances is all but inevitable.  Our corporation’s goal has always been the production of leading seed brands in both large and small-acre crops, with the world’s most innovative in-the-seed trait technologies.  We view the cultivation of marijuana as a revolutionary opportunity for a new product line,” says corporate spokesman Walter Mattias.

Opponents of cannabis use often point to the fact that it contains approximately 483 chemical compounds, and the effects of many of these compounds on the human body is virtually unknown; However, Monsanto appears to have a counter for this.  Though details about Monsanto’s so-called “Super-Hybridized Marijuana Seeds” are currently closely-guarded corporate secrets, an interview with Monsanto’s Chief of Technology, Dr. Robert T. Fraley revealed some basic information.

Dr. Robert T. Fraley states, “Our hybridization of cannabis sativa and cannabis indica has created a unique strain of marijuana that contains considerably less trace compounds and a substantially higher percentage of cannabinoids, specifically tetrahydrocannabinol and cannabidiol, two of the major constituents of medical cannabis.  The result is a much purer product with far fewer trace chemicals than any variety that has heretofore been studied.  Our seeds produce only the female version of the plants, and these plants are hardier, more temperature tolerant and less light-dependent than traditional varieties.”

Congressman Earl Blumenauer, D-Oregon, co-author of the Federal Marijuana Decriminalization bill was asked his feelings on being backed by the vast financial might and peerless technological prowess of the global corporation.  He responded, “We are in the process of a dramatic shift in the marijuana policy landscape.  The support of a corporate powerhouse like Monsanto further legitimizes all of the positive claims and proven scientific benefits of cannabis.”